Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
More Reading from MarketBeat.com 3 Blue-Chip Stocks Built for a Rotating MarketWritten by Chris Markoch. Posted: 3/8/2026. 
Summary - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
Sector rotation describes investors shifting capital out of sectors that look overbought and into ones that appear undervalued. In 2026, that has meant a move away from mega-cap technology names and toward value-oriented, defensive sectors such as energy and consumer staples. The key issue is valuation. Big tech has been running hot for more than two years, driven largely by the emergence of artificial intelligence (AI). Despite concerns about a repeat of the dot-com bubble, many investors largely ignored lofty valuations—until valuation matters again. As the economy begins to heat up, investors are seeking value elsewhere, including in blue-chip defensive names like the stocks below. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Duke is a well-known utility provider in the Southeast and Midwest United States. Utilities stocks are among the most defensive, and are typically viewed as value and income plays. Duke currently offers an attractive, secure dividend yielding around 3.2%, and the company has raised its payout for 20 consecutive years. At the same time, changes in the U.S. energy landscape are opening growth opportunities for DUK. The company takes an "all of the above" approach to generation, including nuclear, hydroelectric and natural gas. Strength in natural gas has helped drive the stock's strong bounce in 2026, while a stable residential utility revenue base and projected growth from areas like data centers add to the appeal. DUK is up nearly 12% in 2026, placing the stock within roughly 5% of its consensus price target of $136.87, which would push it above the 52-week high. Trading at about 20.5x earnings, the stock sits at a slight premium to its historic average. Since the company reported in February, analysts have been raising price targets as they model strong year-over-year revenue growth in the second half of the year—raising the prospect of a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts expect biotechnology stocks to benefit from the current rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within healthcare, a sector that has largely underperformed the broader market. Gilead is a leading provider of HIV therapies, with key drugs protected by patents into the 2030s. Investors are also encouraged by a pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026 and may see a label expansion for its breast cancer drug Trodelvy. GILD is up nearly 18% in 2026 and reached a 52-week high before pulling back slightly—likely a bit of profit-taking after an outsized run. That dip could create a buy-the-dip opportunity. Analysts have a consensus price target of $156.72, implying more than an 8% upside; since February's earnings report many analysts have increased their targets, with the highest calls near $170. Gilead also offers a reliable dividend, yielding about 2.28%, and the company has raised its dividend for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) has been a clear beneficiary of the rotation into consumer staples in 2026. HSY is up nearly 25% this year and has broken out of the bearish trend that began in 2023. The company spent 2023 and 2024 navigating higher cocoa costs that persisted into 2025; those pressures may still weigh on 2026 earnings. However, the market is forward-looking, and analysts are forecasting solid earnings and revenue growth this year. HSY is trading above its consensus price target of $222.21, though analysts have continued to raise targets since the company's February earnings report. The most bullish call comes from Goldman Sachs, which has a $267 target. In that report, Hershey increased its dividend by 5.9%, marking its 15th consecutive annual increase. The stock yields roughly 2.5% and carries an annual payout per share of $5.81. After the recent run-up, HSY trades at over 50x earnings, which likely prompted heavy institutional selling in the last quarter. That valuation could also create an opportunity for investors to find a pullback entry into an otherwise strong consumer-staples name.
| 
